Cspc Pharmaceutical | 1093 - Assets


Cspc Pharmaceutical reported CNY46.7B in Assets for its fiscal quarter ending in December of 2025.





Assets Change Date
Akebia Therapeutics USD 362.52M 14.04M Mar/2026
Alaunos Therapeutics USD 1.88M 1.08M Mar/2026
Avita Medical AUD 56.39M 1.74M Dec/2025
Cspc Pharmaceutical CNY 46.7B 695.56M Dec/2025
Dianthus Therapeutics USD 1.25B 715.96M Mar/2026
Ionis Pharmaceuticals USD 3.45B 74M Mar/2026
IQVIA Holdings USD 29.68B 269M Mar/2026
Jiangsu Hengrui CNY 71.29B 1.43B Mar/2026
Kangmei Pharma CNY 13.31B 375.64M Mar/2026
Moderna USD 11.49B 850M Mar/2026
Organon & Co USD 13B 129M Mar/2026
Revvity USD 12B 171.82M Mar/2026
Sh Fosun Pharma CNY 122.97B 2.91B Mar/2026
Sino Biopharmaceutical CNY 74.89B 9.49B Jun/2025
Tectonic Therapeutic USD 246.58M 14.46M Mar/2026
Viatris USD 36.83B 358.5M Mar/2026
Wuxi Apptec CNY 107.41B 4.29B Mar/2026
Xeris Pharmaceuticals USD 392.01M 8.49M Mar/2026
Zz Pientze Pharmaceu CNY 18.38B 905.93M Mar/2026